Monocyte and endothelial dysfunction induced by hyperglycemia is reversed by Empagliflozin mainly through glucose-transport independent mechanisms

29 August 2022 (10:15 - 10:55)
Organised by:
Congress Presentation Part of: Metabolic syndrome and vascular dysfunction Vascular Diseases ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by